quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:10·1142d
SECFiling
Albireo Pharma Inc. logo

SEC Form EFFECT filed by Albireo Pharma Inc.

ALBO· Albireo Pharma Inc.
Health Care
Original source

Companies

  • ALBO
    Albireo Pharma Inc.
    Health Care

Recent analyst ratings

  • Jan 9UpdateWedbush$42.00
  • Sep 8UpdateGuggenheim$55.00
  • Mar 28UpdateWedbush$75.00
  • Nov 5UpdateHC Wainwright & Co.$80.00
  • Sep 16UpdateWedbush$84.00
  • Jul 21UpdateWedbush$82.00

Related

  • 13D/G799d
    SEC Form SC 13G/A filed by Albireo Pharma Inc. (Amendment)
  • 13D/G1109d
    SEC Form SC 13G/A filed by Albireo Pharma Inc. (Amendment)
  • SEC1136d
    SEC Form 15-12G filed by Albireo Pharma Inc.
  • SEC1142d
    SEC Form EFFECT filed by Albireo Pharma Inc.
  • SEC1142d
    SEC Form EFFECT filed by Albireo Pharma Inc.
  • SEC1142d
    SEC Form EFFECT filed by Albireo Pharma Inc.
  • SEC1142d
    SEC Form EFFECT filed by Albireo Pharma Inc.
  • INSIDER1147d
    SEC Form 4: Chiswell David closing all direct ownership in the company
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022